Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer      
Yazarlar (6)
Yusuf Tutar
Sağlık Bilimleri Üniversitesi, Türkiye
Doç. Dr. Aykut ÖZGÜR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Esen Tutar
Kırşehir Ahi Evran Üniversitesi, Türkiye
Lütfi Tutar
Kırşehir Ahi Evran Üniversitesi, Türkiye
Alessandra Pullıero
Università Degli Studi Di Genova, İtalya
Alberto Izzottı
Università Degli Studi Di Genova, İtalya
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri)
Makale Alt Türü SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale
Dergi Adı Biomedicine and Pharmacotherapy
Dergi ISSN 0753-3322 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q1
Makale Dili İngilizce
Basım Tarihi 10-2016
Cilt No 83
Sayı 1
Sayfalar 1182 / 1190
DOI Numarası 10.1016/j.biopha.2016.08.043
Makale Linki https://www.sciencedirect.com/science/article/abs/pii/S0753332216306916?via%3Dihub
Özet
Lung cancer is one of the most common mortal cancer types both for men and women. Several different biomarkers have been analyzed to reveal lung cancer prognosis pathways for developing efficient therapeutics and diagnostic agents. microRNAs (miRNAs) and pseudogenes are critical biomarkers in lung cancer and alteration of their expression levels has been identified in each step of lung cancer tumorigenesis. miRNAs and pseudogenes are crucial gene regulators in normal cells as well as in lung cancer cells, and they have both oncogenic and tumor-suppressive roles in lung cancer tumorigenesis. In this study, we have determined the relationship between lung cancer related oncogenes and miRNAs along with pseudogenes in lung cancer, and the results indicate their potential as biological markers for diagnostic and therapeutic purposes.
Anahtar Kelimeler
Biomarker | Lung cancer | miRNA | miRNA therapeutics | Pseudogene